Universal Health Services, Inc. (N:UHS)
Business Focus: Healthcare Facilities & Services
| Sector: Healthcare | Industry: Healthcare Facilities & Services |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 367 S GULPH RD KING OF PRUSSIA PA 19406-3121 |
| Tel: | N/A |
| Website: | https://uhs.com |
| IR: | See website |
| Key People | ||
| Alan B. Miller Executive Chairman of the Board | Marc D. Miller President, Chief Executive Officer, Director | Steve G. Filton Chief Financial Officer, Executive Vice President, Secretary |
| Matthew Jay Peterson Executive Vice President, President of Behavioral Health Division | Edward H. Sim Executive Vice President, President - Acute Care Division | |
| Business Overview |
| Universal Health Services, Inc. is a holding company. It operates through its subsidiaries, including its management company. It is engaged in owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. Its segments include acute care hospital services, behavioral health care services, and Other. It owns and operates approximately 360 inpatient facilities and 48 outpatient and other facilities located in 39 states, Washington, D.C., the United Kingdom, and Puerto Rico. It provides services, which include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. It also provides capital resources, as well as a variety of management services to its facilities, including information services, finance and control systems, facilities planning, physician recruitment services, and public relations. |
| Financial Overview |
| For the three months ended 31 March 2024, Universal Health Services, Inc. revenues increased 11% to $3.84B. Net income applicable to common stockholders increased 61% to $261.8M. Revenues reflect Acute Care Hospital Services segment increase of 11% to $2.19B, Utilization of Licensed Beds -%,ACH increase of 4% to 68.6%, Patient Days - BHC increase of 2% to 1.6M. Net income benefited from Other (income) expense. |
| Employees: | 73,350 as of Dec 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $16,621M as of Mar 31, 2024 |
| Annual revenue (TTM): | $14,658M as of Mar 31, 2024 |
| EBITDA (TTM): | $1,853M as of Mar 31, 2024 |
| Net annual income (TTM): | $816.29M as of Mar 31, 2024 |
| Free cash flow (TTM): | $535.74M as of Mar 31, 2024 |
| Net Debt Last Fiscal Year: | $4,750M as of Mar 31, 2024 |
| Shares outstanding: | 66,929,208 as of Apr 30, 2024 |
| Index Membership: | S&P 500 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.